The addition of Philip L. Hirschhorn to Buchanan Ingersoll & Rooney's New York office was noted by multiple media sources, including the October 8, edition of Intellectual Property Today; the October 9 edition of The AmLaw Daily, under the publication's "The Churn" column; and the October 13, edition of IP Law & Business, under its "IP People on the Move" column. In addition, it was the focus of an October 8, article published by Law360.

In the Law360 article, titled "Buchanan Bulks Up With Morgan Lewis IP Atty," Hirschhorn said he was impressed with the firm's "boutique feel coupled with the greater resources of a larger firm," as well as admired the way it was expanding its litigation practice.

"I like the way they are investing in the IP practice, with the growth they've had both recently and intend to have in the future," he said.

The article went on to note that since 1996, his practice has focused almost exclusively on patent litigation, primarily in the fields of pharmaceuticals, medical device and computers.

"As a trial lawyer, Hirschhorn said he had 'very good success' defending drug manufacturers in Hatch-Waxman suits brought by generics makers, as well as patent infringement cases concerning foot pumps, surgical tools and other medical devices," noted the article.

Chairman of the Buchanan's New York Litigation practice Barry I. Slotnick, was quoted on Hirschhorn saying, "Phil's extensive litigation background in intellectual property will complement our service offerings, particularly for our New York-based clients."

Slotnick continued, noting how in recent months, Buchanan has bolstered its litigation offerings in "key areas," adding 10 attorneys to the team in IP, government contracts and family law.

Hirschhorn said he was pleased with the recent additions to the firm. "I think there is a tremendous wealth of IP knowledge here," he said.